For many men, the side effects of prostate cancer treatment can be as daunting as the disease itself. Wildlife photographer Gary tells us how the shock of his diagnosis was compounded by fears of incontinence after having surgery, and what he did to give himself the best chance of preventing it.
BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.
BLOG: Today, Prostate Cancer UK and 67 other charities signed a joint letter to the Prime Minister, urging the government to use the Spring Budget to give the NHS the money it needs to end the current crisis. Our Change Delivery Manager, Martin Abrams, explains why the NHS's whole future is at stake.
After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.
Today's Scottish green light for the chemotherapy drug means the same key treatments for advanced prostate cancer are now routinely available to eligible men in all the home nations.
A new type of treatment that alternately floods and starves the body of testosterone has shown good early results in men with advanced prostate cancer, according to new findings revealed today.
Just 13% of UK's local health commissioners provide adequate care for erectile dysfunction, reveal shocking new figures uncovered by Prostate Cancer UK, leaving thousands of men recovering from prostate cancer treatment struggling with the devastating effects on their health and relationships.
BLOG: While doom-laden reports about chronic underfunding appear daily in the news, the NHS is still committed to transforming cancer treatment in the UK by 2020. So is it all just pie in the sky? Our Policy Manager, Phillip Anderson, doesn't think so, but argues we must get smarter about making our case for investment in prostate cancer if we're going to get the best deal for men.
A new report from the medical professionals' body includes the PSA test as one of 40 medical treatments that may be unnecessary for many men. But Prostate Cancer UK makes clear that the test is still the best first step for diagnosis of prostate cancer while we develop a more robust test suitable for a screening programme.
Following reports in the press yesterday of a US study into androgen deprivation therapy – a commonly used treatment for men with prostate cancer in the UK – Prostate Cancer UK's Dr Iain Le Guilliou investigates whether there's any solid proof behind claims it could double the risk of dementia.